{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Astal Laboratories Ltd
Why is Astal Lab falling/rising?
On 03-Dec, Astal Laboratories Ltd witnessed a notable decline in its share price, falling by 2.37% to close at ₹84.00. This drop reflects a continuation of recent downward momentum amid subdued investor participation and technical weaknesses.
How has been the historical performance of Astal Lab?
Astal Lab experienced significant growth from March 2023 to March 2025, with net sales rising from 3.43 Cr to 64.23 Cr and profit after tax increasing from 0.02 Cr to 8.93 Cr. However, cash flow from operating activities remained negative at -12.00 Cr in March 2025.
Astal Laboratories Faces Cash Flow Challenges Despite Record Sales and Profitability
Astal Laboratories reported record net sales of Rs 37.52 crore for the quarter ending September 2025, with a profit after tax of Rs 7.41 crore for the nine-month period. However, the company faces challenges with negative operating cash flow of Rs -12.52 crore, raising concerns about liquidity and operational efficiency.
Astal Laboratories Q2 FY26: Explosive Growth Meets Margin Compression Concerns
Astal Laboratories Ltd., a micro-cap trading and distribution company with a market capitalisation of ₹96.00 crores, has delivered a quarter of remarkable top-line expansion tempered by margin compression concerns. In Q2 FY26, the company posted net profit of ₹2.58 crores, marking a 23.44% sequential increase from Q1 FY26's ₹2.09 crores and a robust 29.00% year-on-year growth from ₹2.00 crores in Q2 FY25. However, the stock has retreated 7.03% over the past week, trading at ₹88.80 as investors digest the margin dynamics beneath the headline numbers.
Astal Laboratories Experiences Quality Grade Change Amidst Competitive Industry Landscape
Astal Laboratories, a microcap in the Trading & Distributors sector, has shown significant sales growth of 152.08% and EBIT growth of 72.67% over five years. Its financial metrics indicate manageable debt levels, but its return on capital employed and return on equity are relatively low, suggesting potential challenges ahead.
How has been the historical performance of Astal Lab?
Astal Lab has shown significant growth in net sales and profitability from March 2023 to March 2025, with net sales increasing from 3.43 crore to 64.23 crore and profit after tax rising from 0.02 crore to 8.93 crore. However, the company faces cash flow challenges, reporting a negative cash flow from operating activities of 17.00 crore in March 2025.
How has been the historical performance of Astal Lab?
Astal Lab has shown significant growth in net sales and profitability, with net sales increasing from 3.43 Cr in March 2023 to 64.23 Cr in March 2025, and operating profit rising from a loss to 12.90 Cr. However, the company faced cash flow challenges, reporting a net cash outflow of 17.00 Cr in March 2025.
How has been the historical performance of Astal Lab?
Astal Lab has shown significant growth in net sales and profitability from March 2023 to March 2025, with net sales increasing from 3.43 crore to 64.23 crore and operating profit improving from a loss of 0.13 crore to a profit of 12.90 crore. However, cash flow from operating activities remained negative, resulting in a closing cash balance of -10.00 crore by March 2025.
Why is Astal Lab falling/rising?
As of 12-Nov, Astal Laboratories Ltd's stock price is Rs 90.93, down 4.8%, underperforming its sector and the broader market. Recent trends show a significant decline in investor participation and a drop in stock performance over the past week and month.
Astal Laboratories Shows Strong Growth Amid Shift to Mildly Bullish Trend
Astal Laboratories has recently adjusted its evaluation, reflecting changes in its stock's technical landscape. The company reported impressive annual growth in net sales and operating profit, maintaining positive results over six quarters. With a low debt-to-equity ratio and a solid return on capital employed, it remains competitive in the market.
When is the next results date for Astal Lab?
The next results date for Astal Lab is 14 November 2025.
Astal Laboratories Adjusts Evaluation Amid Strong Sales Growth and Management Efficiency Challenges
Astal Laboratories has recently adjusted its evaluation, reflecting changes in the stock's technical landscape. The company boasts strong financial metrics, including a low Debt to Equity ratio and impressive growth in net sales and operating profit. However, it faces challenges in management efficiency, as indicated by its Return on Equity.
How has been the historical performance of Astal Lab?
Astal Lab has shown significant growth, with net sales increasing from 3.43 Cr in March 2023 to 64.23 Cr in March 2025, and operating profit shifting from a loss of 0.13 Cr to a profit of 12.90 Cr. However, it faces challenges with negative cash flow from operating activities, totaling a cash outflow of 12.00 Cr in March 2025.
Astal Laboratories Shows Strong Growth Amid Mixed Technical Indicators and Market Sentiment
Astal Laboratories has recently experienced a score adjustment reflecting changes in its technical outlook. The company has shown strong performance with a year-to-date return of 24.69% and significant growth in net sales and operating profit. Its financial structure remains conservative, with a low debt-to-equity ratio.
How has been the historical performance of Astal Lab?
Astal Lab has demonstrated significant growth from March 2023 to March 2025, with net sales increasing from 3.43 crore to 64.23 crore and operating profit rising from a loss of 0.13 crore to a profit of 12.90 crore. Despite this growth, the company faced negative cash flow, ending with a cash balance of -10.00 crore.
Is Astal Lab overvalued or undervalued?
As of October 9, 2025, Astal Lab is fairly valued with a PE ratio of 11.39 and strong performance, having outpaced the Sensex with a year-to-date return of 21.73%.
Why is Astal Lab falling/rising?
As of 07-Oct, Astal Laboratories Ltd's stock price has risen to Rs 97.20, up 5.27%, with strong recent performance, gaining 17.22% in the past week and 18.31% in the last month. Despite a year-over-year decline of 8.73%, the stock has significantly outperformed the Sensex in the short term, indicating positive investor sentiment.
Why is Astal Lab falling/rising?
As of 06-October, Astal Laboratories Ltd's stock price is rising to 93.50, reflecting a 7.02% increase and strong performance, outperforming its sector and the benchmark Sensex. The stock has shown consistent gains, with significant investor interest indicated by increased delivery volume.
Astal Laboratories Shows Stabilization Amid Strong Sales Growth and Profitability Challenges
Astal Laboratories has recently adjusted its evaluation, reflecting changes in technical trends. The company reported impressive annual growth in net sales and operating profit, alongside consistent positive results over six quarters. However, it faces challenges with a low return on equity and has underperformed relative to the broader market.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
